Poland - Wrocław: Medical equipments, pharmaceuticals and personal care products

Release

ID: ocds-pyfy63:2022-123986:2023-331179
Buyer: Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii
Date: 2023-06-05
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2022-123986
Releases: 2022-03-09 (ocds-pyfy63:2022-123986:2022-123986)
2022-04-04 (ocds-pyfy63:2022-123986:2022-173999)
2022-04-08 (ocds-pyfy63:2022-123986:2022-184526)
2023-06-05 (ocds-pyfy63:2022-123986:2023-331179)

Releases in JSON

Tender

Title: Poland - Wrocław: Medical equipments, pharmaceuticals and personal care products
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price

Award criteria for item 66:
- Price

Award criteria for item 67:
- Price

Award criteria for item 68:
- Price

Award criteria for item 69:
- Price

Award criteria for item 70:
- Price

Award criteria for item 71:
- Price

Award criteria for item 72:
- Price

Award criteria for item 73:
- Price

Award criteria for item 74:
- Price

Award criteria for item 75:
- Price

Award criteria for item 76:
- Price

Award criteria for item 77:
- Price

Award criteria for item 78:
- Price

Award criteria for item 79:
- Price

Award criteria for item 80:
- Price

Award criteria for item 81:
- Price

Award criteria for item 82:
- Price

Award criteria for item 83:
- Price

Award criteria for item 84:
- Price

Award criteria for item 85:
- Price

Award criteria for item 86:
- Price

Award criteria for item 87:
- Price

Award criteria for item 88:
- Price

Award criteria for item 89:
- Price

Award criteria for item 90:
- Price

Award criteria for item 91:
- Price

Award criteria for item 92:
- Price

Award criteria for item 93:
- Price

Award criteria for item 94:
- Price

Award criteria for item 95:
- Price

Award criteria for item 96:
- Price

Award criteria for item 97:
- Price

Award criteria for item 98:
- Price

Award criteria for item 99:
- Price

Award criteria for item 100:
- Price

Award criteria for item 101:
- Price

Award criteria for item 102:
- Price

Award criteria for item 103:
- Price

Award criteria for item 104:
- Price

Award criteria for item 105:
- Price

Award criteria for item 106:
- Price

Award criteria for item 107:
- Price

Award criteria for item 108:
- Price

Award criteria for item 109:
- Price

Award criteria for item 110:
- Price

Award criteria for item 111:
- Price

Award criteria for item 112:
- Price

Award criteria for item 113:
- Price

Award criteria for item 114:
- Price

Award criteria for item 115:
- Price

Award criteria for item 116:
- Price

Award criteria for item 117:
- Price

Award criteria for item 118:
- Price

Award criteria for item 119:
- Price

Award criteria for item 120:
- Price

Award criteria for item 121:
- Price

Award criteria for item 122:
- Price

Award criteria for item 123:
- Price

Award criteria for item 124:
- Price

Award criteria for item 125:
- Price

Award criteria for item 126:
- Price

Award criteria for item 127:
- Price

Award criteria for item 128:
- Price

Award criteria for item 129:
- Price

Award criteria for item 130:
- Price

Award criteria for item 131:
- Price

Award criteria for item 132:
- Price

Award criteria for item 133:
- Price

Award criteria for item 134:
- Price

Award criteria for item 135:
- Price

Award criteria for item 136:
- Price

Award criteria for item 137:
- Price

Award criteria for item 138:
- Price

Award criteria for item 139:
- Price

Award criteria for item 140:
- Price

Award criteria for item 141:
- Price

Award criteria for item 142:
- Price

Award criteria for item 143:
- Price

Award criteria for item 144:
- Price

Award criteria for item 145:
- Price

Award criteria for item 146:
- Price

Award criteria for item 147:
- Price

Award criteria for item 148:
- Price

Award criteria for item 149:
- Price

Award criteria for item 150:
- Price

Award criteria for item 151:
- Price

Award criteria for item 152:
- Price

Award criteria for item 153:
- Price

Award criteria for item 154:
- Price

Award criteria for item 155:
- Price

Award criteria for item 156:
- Price

Award criteria for item 157:
- Price

Award criteria for item 158:
- Price

Award criteria for item 159:
- Price

Award criteria for item 160:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2023-06-05 - ?
Tenderers: URTICA SP. Z. O.O.
JANSSEN-CILAG POLSKA SP. Z O.O.
URTICA SP. Z O.O.
SANOFI-AVENTIS SP. Z O.O.
ROCHE POLSKA SP. Z O.O.
ASCLEPIOS S.A.
Lek S.A.
SALUS INTERNATIONAL SP. Z O.O.
CENTRALA FARMACEUTYCZNA CEFARM SA
Urtica Sp. z o.o.
Amgen SP. z o.o.
PFIZER TRADING POLSKA SP. Z O.O.
Takeda Pharma sp. z o.o.
Bialmed Sp. z o.o.
Sanofi-Aventis Sp. z o.o.
Salus International Sp. z o.o.
Asclepios S.A.
BAXTER POLSKA SP. Z O.O.
Janssen-Cilag Polska Sp. z o.o.
Urtica Sp. z o.o.
Asclepios S.A.
Baxter Polska Sp. z o.o.
Astellas Pharma Sp. z o.o.
Lek S.A.
Pfizer Trading Polska Sp. z o.o.
Salus International Sp. z o.o.
Salus International Sp. z o.o.
Fresenius Nephrocare Polska Sp. z o.o.
Takeda Pharma sp. z o.o.
Takeda Pharma sp. z o.o.
Komtur Polska Sp. z o.o.
TRAMCO SP. Z O.O.
Storkpharm Sp. z o.o.
Bialmed Sp. z o.o.
Roche Polska Sp. z o.o
GSK Services Sp. z o.o
Roche Polska Sp. z o.o
Asclepios S.A.
Amgen Sp. z o.o.
Urtica Sp. z o.o.
SERVIER POLSKA SERVICES SP.
NEUCA S.A.
Urtica Sp. z o.o.
Roche Polska Sp. z o.o
Komtur Polska Sp. z o.o.
Salus International Sp. z o.o.
Bialmed Sp. z o.o.
Egis Polska Dystrybucja Sp. z o.o.
Egis Polska Dystrybucja Sp. z o.o.
Pfizer Trading Polska Sp. z o.o.
Imed Poland Sp. z o.o.
ASCLEPIOS S.A.
SERVIER POLSKA SERVICES SP. Z O.O.
Takeda Pharma sp. z o.o.
ABBVIE sp. z o.o.
Storkpharm Sp. z o.o.

Tender item

ID: ocds-pyfy63:2022-123986:obj:1
Classification: CPV / 33000000
Description: tabl.powl. 150 mg lub tabl.powl. 100 mg lub tabl.powl. 50 mg70/ 400

Tender item

ID: ocds-pyfy63:2022-123986:obj:2
Classification: CPV / 33000000
Description: tabletki 500 mg60/ 580

Tender item

ID: ocds-pyfy63:2022-123986:obj:3
Classification: CPV / 33000000
Description: tabl.powl. 40 mg, tabl.powl. 20 mg, tabl.powl. 30 mg28/ 100

Tender item

ID: ocds-pyfy63:2022-123986:obj:4
Classification: CPV / 33000000
Description: fiol.200mg/8ml1 /360

Tender item

ID: ocds-pyfy63:2022-123986:obj:5
Classification: CPV / 33000000
Description: kaps.tw. 150 mg224/ 180

Tender item

ID: ocds-pyfy63:2022-123986:obj:6
Classification: CPV / 33000000
Description: kaps.twarde 1mg100/ 100

Tender item

ID: ocds-pyfy63:2022-123986:obj:7
Classification: CPV / 33000000
Description: Koncentrat do sporządzania roztworu do infuzji fiol. 10 mg/10ml10/ 20

Tender item

ID: ocds-pyfy63:2022-123986:obj:8
Classification: CPV / 33000000
Description: fiolka 1200 mg1 /800

Tender item

ID: ocds-pyfy63:2022-123986:obj:9
Classification: CPV / 33000000
Description: fiol.100 mg/ 4ml1/ 2200

Tender item

ID: ocds-pyfy63:2022-123986:obj:10
Classification: CPV / 33000000
Description: fiol. z proszkiem + system do rozpuszcz. i podaw. z rozp. 50 ml; proszek i rozpuszczalnik do sporządzania zawiesiny do podawania do pęcherza moczowego; jedna fiolka (1 dawka) po odtworzeniu zaiera nie mniej niż 2x10^8 i nie więcej niż 3x10^9 żywych cząstek BCG (Bacillus Calmette-Guerin). 1/ 800wymaga się zaoferowania produktu w postaci zestawu do podawania BCG terapii dopęcherzowej pozwalający na przygotowanie i podanie szczepionki BCG dopęcherzowo w sposób zamknięty. Zestaw jednorazowy, pakowany indywidualnie.

Tender item

ID: ocds-pyfy63:2022-123986:obj:11
Classification: CPV / 33000000
Description: 1 fiol. proszku + 1 amp. rozp.; proszek i rozpuszczalnik do sporządzania zawiesiny do podawania do pęcherza moczowego; dawka 100 mg (nie mniej niż 300 mln żywych prątków BCG)/ml1/ 1400

Tender item

ID: ocds-pyfy63:2022-123986:obj:12
Classification: CPV / 33000000
Description: fiolki 100 mg5/ 100

Tender item

ID: ocds-pyfy63:2022-123986:obj:13
Classification: CPV / 33000000
Description: tabl.powl.15mg84/ 420

Tender item

ID: ocds-pyfy63:2022-123986:obj:14
Classification: CPV / 33000000
Description: fiol/15000 IU1 /800

Tender item

ID: ocds-pyfy63:2022-123986:obj:15
Classification: CPV / 33000000
Description: 1 fiol. proszku 38,5 mcg + 1 fiol. roztworu stabilizującego 10 ml1/40

Tender item

ID: ocds-pyfy63:2022-123986:obj:16
Classification: CPV / 33000000
Description: tabl.powl.500 mg28/ 70

Tender item

ID: ocds-pyfy63:2022-123986:obj:17
Classification: CPV / 33000000
Description: fiol.50 mg1/ 320

Tender item

ID: ocds-pyfy63:2022-123986:obj:18
Classification: CPV / 33000000
Description: fiol. 60 mg1/ 35Wymaga się zaoferowania produktu, który po przygotowaniu do podania pacjentowi (gotowy roztwór) ma potwierdzoną stabilność chemiczną i fizyczną po rozcieńczeniu 5% roztworem glukozy lub 9 mg/ml (0,9%) roztworem chlorku sodu do wstrzykiwań w okresie 15 godzin po rozcieńczeniu, pod warunkiem przechowywania w temperaturze 2°C - 8°C, a następnie w okresie 3 godzin przechowywania w temperaturze 20°C ± 5°C (w tym czas wlewu).

Tender item

ID: ocds-pyfy63:2022-123986:obj:19
Classification: CPV / 33000000
Description: tabl.powl. 20 mg lub tabl.powl. 40 mg lub tabl.powl. 60 mg30/ 170

Tender item

ID: ocds-pyfy63:2022-123986:obj:20
Classification: CPV / 33000000
Description: tabletki powlekane 500 mg120/ 3100

Tender item

ID: ocds-pyfy63:2022-123986:obj:21
Classification: CPV / 33000000
Description: fiol.600 mg / 60 ml1/ 4500Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:22
Classification: CPV / 33000000
Description: fiol.10 mg1/ 2400

Tender item

ID: ocds-pyfy63:2022-123986:obj:23
Classification: CPV / 33000000
Description: fiol. 100 mg 1/ 160

Tender item

ID: ocds-pyfy63:2022-123986:obj:24
Classification: CPV / 33000000
Description: fiol.350 mg1/ 75

Tender item

ID: ocds-pyfy63:2022-123986:obj:25
Classification: CPV / 33000000
Description: kaps. twarda 150 mg150/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:26
Classification: CPV / 33000000
Description: fiolka 500 mg1/ 1750

Tender item

ID: ocds-pyfy63:2022-123986:obj:27
Classification: CPV / 33000000
Description: amp. 50 mg/ml10/ 320

Tender item

ID: ocds-pyfy63:2022-123986:obj:28
Classification: CPV / 33000000
Description: kaps. 50 mg50/ 30

Tender item

ID: ocds-pyfy63:2022-123986:obj:29
Classification: CPV / 33000000
Description: kaps. 100 mg50/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:30
Classification: CPV / 33000000
Description: kaps. 25 mg50/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:31
Classification: CPV / 33000000
Description: fiol. 100mg1/ 4000Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 2 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:32
Classification: CPV / 33000000
Description: fiol.10 mg1/ 50

Tender item

ID: ocds-pyfy63:2022-123986:obj:33
Classification: CPV / 33000000
Description: tabl.powl.20 mg63/ 90

Tender item

ID: ocds-pyfy63:2022-123986:obj:34
Classification: CPV / 33000000
Description: kaps. twarda 250mg60/ 40

Tender item

ID: ocds-pyfy63:2022-123986:obj:35
Classification: CPV / 33000000
Description: fiol.1000 mg 1/ 3500

Tender item

ID: ocds-pyfy63:2022-123986:obj:36
Classification: CPV / 33000000
Description: drażetki 50 mg50/ 60

Tender item

ID: ocds-pyfy63:2022-123986:obj:37
Classification: CPV / 33000000
Description: fiol. 1g/20ml1/ 1000Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 28 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:38
Classification: CPV / 33000000
Description: kapsułki twarde 75mg28/ 1400

Tender item

ID: ocds-pyfy63:2022-123986:obj:39
Classification: CPV / 33000000
Description: fiol. 500mg1/ 1200

Tender item

ID: ocds-pyfy63:2022-123986:obj:40
Classification: CPV / 33000000
Description: fiol. 0,5 mg1/ 30

Tender item

ID: ocds-pyfy63:2022-123986:obj:41
Classification: CPV / 33000000
Description: fiol. 400 mg1/ 60

Tender item

ID: ocds-pyfy63:2022-123986:obj:42
Classification: CPV / 33000000
Description: tabl. powl. 100 mg30/ 120

Tender item

ID: ocds-pyfy63:2022-123986:obj:43
Classification: CPV / 33000000
Description: fiol. 20 mg1/ 500

Tender item

ID: ocds-pyfy63:2022-123986:obj:44
Classification: CPV / 33000000
Description: fiol. 160 mg1/ 2200Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:45
Classification: CPV / 33000000
Description: fiol. 20mg 1/ 1800

Tender item

ID: ocds-pyfy63:2022-123986:obj:46
Classification: CPV / 33000000
Description: fiol.50 mg 2/ 260

Tender item

ID: ocds-pyfy63:2022-123986:obj:47
Classification: CPV / 33000000
Description: fiol.200 mg/100ml1/ 1500Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:48
Classification: CPV / 33000000
Description: fiol. 500 mg 1/ 500

Tender item

ID: ocds-pyfy63:2022-123986:obj:49
Classification: CPV / 33000000
Description: kaps.twarde 75 mg42/ 860

Tender item

ID: ocds-pyfy63:2022-123986:obj:50
Classification: CPV / 33000000
Description: kaps.miękka 40 mg112/ 900

Tender item

ID: ocds-pyfy63:2022-123986:obj:51
Classification: CPV / 33000000
Description: fiol.100 mg/50ml1/ 360

Tender item

ID: ocds-pyfy63:2022-123986:obj:52
Classification: CPV / 33000000
Description: tabl. powl. 150mg30/ 60

Tender item

ID: ocds-pyfy63:2022-123986:obj:53
Classification: CPV / 33000000
Description: fiol. 400 mg1/ 2000

Tender item

ID: ocds-pyfy63:2022-123986:obj:54
Classification: CPV / 33000000
Description: tabl. 10 mg30/ 120Wymagana jest realizacja dostaw produktu, który jest refundowany w leczeniu raka nerki i nowotworu neuroendokrynnego trzustki.

Tender item

ID: ocds-pyfy63:2022-123986:obj:55
Classification: CPV / 33000000
Description: kaps. 100 mg120/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:56
Classification: CPV / 33000000
Description: ampstrz.30 mln j.m./0,5 ml1/ 3000

Tender item

ID: ocds-pyfy63:2022-123986:obj:57
Classification: CPV / 33000000
Description: ampstrz. 48 mln j.m./0,8 ml1/ 2000

Tender item

ID: ocds-pyfy63:2022-123986:obj:58
Classification: CPV / 33000000
Description: tabl.powl.10 mg20/ 54

Tender item

ID: ocds-pyfy63:2022-123986:obj:59
Classification: CPV / 33000000
Description: fiol. 50 mg5/ 36

Tender item

ID: ocds-pyfy63:2022-123986:obj:60
Classification: CPV / 33000000
Description: fiol. 5 g1/ 4200Wymagane jest zaoferowanie produktu, który wykazuje zgodność farmaceutyczną w połączeniu z roztworem acidum levofolinicum (w postaci preparatu wymienionego w Obwieszczeniu Ministra Zdrowia „w sprawie wykazu leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych” w części B i/lub C załącznika) i tworzy z nim stabilną mieszaninę.

Tender item

ID: ocds-pyfy63:2022-123986:obj:61
Classification: CPV / 33000000
Description: ampstrz. 250 mg2/ 1500

Tender item

ID: ocds-pyfy63:2022-123986:obj:62
Classification: CPV / 33000000
Description: tabl.powl.250mg30/ 60

Tender item

ID: ocds-pyfy63:2022-123986:obj:63
Classification: CPV / 33000000
Description: fiol. 2000 mg1/ 2000Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:64
Classification: CPV / 33000000
Description: Proszek do sporządzania koncentratu roztworu do infuzji 5 mg1/ 6

Tender item

ID: ocds-pyfy63:2022-123986:obj:65
Classification: CPV / 33000000
Description: kaps. twarde 500 mg100/ 20

Tender item

ID: ocds-pyfy63:2022-123986:obj:66
Classification: CPV / 33000000
Description: kaps.tward.140mg90/ 90

Tender item

ID: ocds-pyfy63:2022-123986:obj:67
Classification: CPV / 33000000
Description: Proszek do sporządzania roztworu do wstrzykiwań 10 mg1/ 50

Tender item

ID: ocds-pyfy63:2022-123986:obj:68
Classification: CPV / 33000000
Description: fiol.2g1/ 1200

Tender item

ID: ocds-pyfy63:2022-123986:obj:69
Classification: CPV / 33000000
Description: tabl.powl.400 mg30/ 1200Wymagana jest realizacja dostaw produktu, który jest refundowany we wskazaniu do leczenia nowotworów podścieliska przewodu pokarmowego (GIST).

Tender item

ID: ocds-pyfy63:2022-123986:obj:70
Classification: CPV / 33000000
Description: "tabl.powl. 400mg"30/ 300Wymagana jest realizacja dostaw produktu, który jest refundowany w nowotworze - zaawansowany włókniakomięsak guzowaty skóry.

Tender item

ID: ocds-pyfy63:2022-123986:obj:71
Classification: CPV / 33000000
Description: fiolka 100 mg/5 ml10/ 36

Tender item

ID: ocds-pyfy63:2022-123986:obj:72
Classification: CPV / 33000000
Description: IG 10% fiolka 30g + rHuPH20, 1 fiol. 30g/300 ml + 1 fiol. 10 ml/ 120

Tender item

ID: ocds-pyfy63:2022-123986:obj:73
Classification: CPV / 33000000
Description: fiol. 2,5 g/50 ml1/ 36wymagane jest zaoferowanie produktu, który jest wskazany w leczeniu zakażeń bakteryjnych przy równoczesnym stosowaniu antybiotyków, substytucja immunoglobulin u pacjentów o osłabionym układzie immunologicznym

Tender item

ID: ocds-pyfy63:2022-123986:obj:74
Classification: CPV / 33000000
Description: ffiol. 5g/100 ml1/ 18wymagane jest zaoferowanie produktu, który jest wskazany w leczeniu zakażeń bakteryjnych przy równoczesnym stosowaniu antybiotyków, substytucja immunoglobulin u pacjentów o osłabionym układzie immunologicznym

Tender item

ID: ocds-pyfy63:2022-123986:obj:75
Classification: CPV / 33000000
Description: fiol.10 g/100ml1/ 600

Tender item

ID: ocds-pyfy63:2022-123986:obj:76
Classification: CPV / 33000000
Description: fiol.10 g/100ml1/ 300

Tender item

ID: ocds-pyfy63:2022-123986:obj:77
Classification: CPV / 33000000
Description: fiol. 1 g/5 ml1/ 6000

Tender item

ID: ocds-pyfy63:2022-123986:obj:78
Classification: CPV / 33000000
Description: fiol. 1g/5 ml1/ 3000

Tender item

ID: ocds-pyfy63:2022-123986:obj:79
Classification: CPV / 33000000
Description: fiol. 100 mg 1/ 20

Tender item

ID: ocds-pyfy63:2022-123986:obj:80
Classification: CPV / 33000000
Description: fiol. 50 mg1/ 720

Tender item

ID: ocds-pyfy63:2022-123986:obj:81
Classification: CPV / 33000000
Description: fiol. 500 mg1/ 2000Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania

Tender item

ID: ocds-pyfy63:2022-123986:obj:82
Classification: CPV / 33000000
Description: kaps. twarde 4 mg3/ 5

Tender item

ID: ocds-pyfy63:2022-123986:obj:83
Classification: CPV / 33000000
Description: amp.strz.120mg1/ 650

Tender item

ID: ocds-pyfy63:2022-123986:obj:84
Classification: CPV / 33000000
Description: tabl. powl. 250 mg70/ 300

Tender item

ID: ocds-pyfy63:2022-123986:obj:85
Classification: CPV / 33000000
Description: kaps.twarde 25 mg21/ 160

Tender item

ID: ocds-pyfy63:2022-123986:obj:86
Classification: CPV / 33000000
Description: kaps.twarde 5 mg21/ 70

Tender item

ID: ocds-pyfy63:2022-123986:obj:87
Classification: CPV / 33000000
Description: kaps.twarde 10 mg21/ 70

Tender item

ID: ocds-pyfy63:2022-123986:obj:88
Classification: CPV / 33000000
Description: kaps.twarde 15 mg21/ 90

Tender item

ID: ocds-pyfy63:2022-123986:obj:89
Classification: CPV / 33000000
Description: kaps. 40 mg10/ 70

Tender item

ID: ocds-pyfy63:2022-123986:obj:90
Classification: CPV / 33000000
Description: tabl. powl. 100 mg30/ 18

Tender item

ID: ocds-pyfy63:2022-123986:obj:91
Classification: CPV / 33000000
Description: zawiesina 240 ml1/ 180

Tender item

ID: ocds-pyfy63:2022-123986:obj:92
Classification: CPV / 33000000
Description: fiol. 50 mg 1/ 380

Tender item

ID: ocds-pyfy63:2022-123986:obj:93
Classification: CPV / 33000000
Description: tabl.powl. 2 mg 25/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:94
Classification: CPV / 33000000
Description: fiol. 5000 mg1/ 50

Tender item

ID: ocds-pyfy63:2022-123986:obj:95
Classification: CPV / 33000000
Description: amp. 20 mcg/ml;50/ 6

Tender item

ID: ocds-pyfy63:2022-123986:obj:96
Classification: CPV / 33000000
Description: kaps. miękkie 25 mg56/ 18

Tender item

ID: ocds-pyfy63:2022-123986:obj:97
Classification: CPV / 33000000
Description: fiol. 20 mg1/ 300

Tender item

ID: ocds-pyfy63:2022-123986:obj:98
Classification: CPV / 33000000
Description: fiolka 20 mg1/ 120

Tender item

ID: ocds-pyfy63:2022-123986:obj:99
Classification: CPV / 33000000
Description: fiol.500 mg4/ 50

Tender item

ID: ocds-pyfy63:2022-123986:obj:100
Classification: CPV / 33000000
Description: roztwór do infuzji 250 mg1/ 380

Tender item

ID: ocds-pyfy63:2022-123986:obj:101
Classification: CPV / 33000000
Description: kaps.twarda 200mg112/ 140

Tender item

ID: ocds-pyfy63:2022-123986:obj:102
Classification: CPV / 33000000
Description: kapsułki miękkie 100 mg120/ 40Wymagana jest realizacja dostaw produktu, który jest refundowany w leczeniu niedrobnokomórkowego raka płuca (B.63)

Tender item

ID: ocds-pyfy63:2022-123986:obj:103
Classification: CPV / 33000000
Description: kapsułki miękkie 150 mg60/ 6Wymagana jest realizacja dostaw produktu, który jest refundowany w leczeniu niedrobnokomórkowego raka płuca (B.63)

Tender item

ID: ocds-pyfy63:2022-123986:obj:104
Classification: CPV / 33000000
Description: kapsułki miękkie 150 mg60/ 300Wymagana jest realizacja dostaw produktu, który jest refundowany w leczeniu idiopatycznego włóknienia płuc (B.87)

Tender item

ID: ocds-pyfy63:2022-123986:obj:105
Classification: CPV / 33000000
Description: kaps.twarde 100 mg84/ 90

Tender item

ID: ocds-pyfy63:2022-123986:obj:106
Classification: CPV / 33000000
Description: fiol.100 mg1/ 6000 lek1/ 2500 filtr

Tender item

ID: ocds-pyfy63:2022-123986:obj:107
Classification: CPV / 33000000
Description: fiol.1 g1/ 240

Tender item

ID: ocds-pyfy63:2022-123986:obj:108
Classification: CPV / 33000000
Description: tabl.powl.150mg56/ 1000

Tender item

ID: ocds-pyfy63:2022-123986:obj:109
Classification: CPV / 33000000
Description: tabl.powl.80 mg30/ 400

Tender item

ID: ocds-pyfy63:2022-123986:obj:110
Classification: CPV / 33000000
Description: fiolka 200 mg1/ 3200Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:111
Classification: CPV / 33000000
Description: fiol.600 mg - fiolki do wielokrotnego pobrania1/ 2200Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania. Ponadto wymagana jest trwałość leku (chemiczna i fizyczna stabilność) w temperaturze pokojowej (do 25°C) po rozpuszczeniu (przygotowaniu dla pacjenta) minimum 26 godzin – warunek ten musi być jednoznacznie potwierdzony w charakterystyce produktu lub innym, dostarczonym dokumencie.

Tender item

ID: ocds-pyfy63:2022-123986:obj:112
Classification: CPV / 33000000
Description: fiol.100mg1/ 600

Tender item

ID: ocds-pyfy63:2022-123986:obj:113
Classification: CPV / 33000000
Description: kaps.twarde. 125 mg21/ 650

Tender item

ID: ocds-pyfy63:2022-123986:obj:114
Classification: CPV / 33000000
Description: fiol.400 mg1/ 1000

Tender item

ID: ocds-pyfy63:2022-123986:obj:115
Classification: CPV / 33000000
Description: tabl.powl. 400 mg60/ 250

Tender item

ID: ocds-pyfy63:2022-123986:obj:116
Classification: CPV / 33000000
Description: fiol. 3750 j.m./5ml1/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:117
Classification: CPV / 33000000
Description: amp.strz. 6 mg/0,6 ml1/1800

Tender item

ID: ocds-pyfy63:2022-123986:obj:118
Classification: CPV / 33000000
Description: ampułkostrzykawka 90 mcg/0,5ml1/60

Tender item

ID: ocds-pyfy63:2022-123986:obj:119
Classification: CPV / 33000000
Description: ampułkostrzykawka 135 mcg/0,5ml1/20

Tender item

ID: ocds-pyfy63:2022-123986:obj:120
Classification: CPV / 33000000
Description: fiolka 100 mg1/ 4600 lek1/ 2300 zestaw do infuzjiWymagane jest zaoferowanie 2300 filtrów wymaganych do podania leku pacjentowi zgodnego z wymaganiami Charakterystyki Produktu Leczniczego.

Tender item

ID: ocds-pyfy63:2022-123986:obj:121
Classification: CPV / 33000000
Description: fiol. 500 mg1/ 1800

Tender item

ID: ocds-pyfy63:2022-123986:obj:122
Classification: CPV / 33000000
Description: fiol. 420mg1/ 1400

Tender item

ID: ocds-pyfy63:2022-123986:obj:123
Classification: CPV / 33000000
Description: tabl. powl.. 267 mg po 252 szt. lub tabl.powl. 801 mg po 84 szt.252 lub 84 zgodnie z opisem kol. 6/ 252

Tender item

ID: ocds-pyfy63:2022-123986:obj:124
Classification: CPV / 33000000
Description: fiol.24mg/1,2ml1/ 18

Tender item

ID: ocds-pyfy63:2022-123986:obj:125
Classification: CPV / 33000000
Description: Proszek do sporządzania koncentratu roztworu do infuzji 140 mg1/ 6

Tender item

ID: ocds-pyfy63:2022-123986:obj:126
Classification: CPV / 33000000
Description: kaps.tw. 4 mg, kaps.tw. 3 mg, kaps.tw. 2 mg, kaps.tw. 1 mg21/ 5

Tender item

ID: ocds-pyfy63:2022-123986:obj:127
Classification: CPV / 33000000
Description: tabl. powl. 45 mg w opak. 30 szt.lub tabl.powl.15 mg w opak.60 szt.30 lub 60 zgodnie z opisem kol.6/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:128
Classification: CPV / 33000000
Description: kaps. 50 mg50/ 60

Tender item

ID: ocds-pyfy63:2022-123986:obj:129
Classification: CPV / 33000000
Description: tabl.powl.200 mg63/ 680

Tender item

ID: ocds-pyfy63:2022-123986:obj:130
Classification: CPV / 33000000
Description: tabl.5 mg56/ 75

Tender item

ID: ocds-pyfy63:2022-123986:obj:131
Classification: CPV / 33000000
Description: tabl.20 mg56/ 150

Tender item

ID: ocds-pyfy63:2022-123986:obj:132
Classification: CPV / 33000000
Description: tabl.powl. 1 mg 30/ 12

Tender item

ID: ocds-pyfy63:2022-123986:obj:133
Classification: CPV / 33000000
Description: tabl.powl. 200 mg112/ 200

Tender item

ID: ocds-pyfy63:2022-123986:obj:134
Classification: CPV / 33000000
Description: kaps. twarda 25 mg28/ 320

Tender item

ID: ocds-pyfy63:2022-123986:obj:135
Classification: CPV / 33000000
Description: kaps. twarda 50 mg28/160

Tender item

ID: ocds-pyfy63:2022-123986:obj:136
Classification: CPV / 33000000
Description: kaps. 1 mg30/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:137
Classification: CPV / 33000000
Description: kaps. 0,5 mg30/ 10

Tender item

ID: ocds-pyfy63:2022-123986:obj:138
Classification: CPV / 33000000
Description: kapsułka twarda 100 mg5/ 1600

Tender item

ID: ocds-pyfy63:2022-123986:obj:139
Classification: CPV / 33000000
Description: fiol. 30mg/1,2 ml1/420

Tender item

ID: ocds-pyfy63:2022-123986:obj:140
Classification: CPV / 33000000
Description: tabl. 100 mg30/ 100

Tender item

ID: ocds-pyfy63:2022-123986:obj:141
Classification: CPV / 33000000
Description: fiol.100 mg1/ 18

Tender item

ID: ocds-pyfy63:2022-123986:obj:142
Classification: CPV / 33000000
Description: fiol.4mg1/ 700

Tender item

ID: ocds-pyfy63:2022-123986:obj:143
Classification: CPV / 33000000
Description: kaps.twarde 1 mg10/ 80

Tender item

ID: ocds-pyfy63:2022-123986:obj:144
Classification: CPV / 33000000
Description: kaps.twarde 0,25 mg10/ 60

Tender item

ID: ocds-pyfy63:2022-123986:obj:145
Classification: CPV / 33000000
Description: fiol.1 mg 1/180

Tender item

ID: ocds-pyfy63:2022-123986:obj:146
Classification: CPV / 33000000
Description: tabl.powl.2 mg30/ 350

Tender item

ID: ocds-pyfy63:2022-123986:obj:147
Classification: CPV / 33000000
Description: fiolka. 100 mg1/1000

Tender item

ID: ocds-pyfy63:2022-123986:obj:148
Classification: CPV / 33000000
Description: fiol. 600mg1/2000

Tender item

ID: ocds-pyfy63:2022-123986:obj:149
Classification: CPV / 33000000
Description: fiolka 150 mg1/4200

Tender item

ID: ocds-pyfy63:2022-123986:obj:150
Classification: CPV / 33000000
Description: kapsułki miękkie 10 mg100/ 20

Tender item

ID: ocds-pyfy63:2022-123986:obj:151
Classification: CPV / 33000000
Description: tabl.powl, 20+8,19 mg 60/500

Tender item

ID: ocds-pyfy63:2022-123986:obj:152
Classification: CPV / 33000000
Description: fiol.300 mg1/12

Tender item

ID: ocds-pyfy63:2022-123986:obj:153
Classification: CPV / 33000000
Description: tabl.powl. 240mg56/ 500

Tender item

ID: ocds-pyfy63:2022-123986:obj:154
Classification: CPV / 33000000
Description: tabl.powl.100 mg112/ 240

Tender item

ID: ocds-pyfy63:2022-123986:obj:155
Classification: CPV / 33000000
Description: fiol. 10 mg1/700

Tender item

ID: ocds-pyfy63:2022-123986:obj:156
Classification: CPV / 33000000
Description: fiol.1 mg1/ 1600

Tender item

ID: ocds-pyfy63:2022-123986:obj:157
Classification: CPV / 33000000
Description: kapsułki miękkie 30 mg1/6500

Tender item

ID: ocds-pyfy63:2022-123986:obj:158
Classification: CPV / 33000000
Description: fiol. 50mg10/ 50Wymagana jest realizacja dostaw produktu, który jest wskazany w leczeniu zaawansowanego niedrobnokomórkowego raka płuca (we wszystkich stopniach zaawansowania).

Tender item

ID: ocds-pyfy63:2022-123986:obj:159
Classification: CPV / 33000000
Description: fiol. 50mg1/ 1000Wymaga się zaoferowania produktu w postaci koncentratu lub roztworu, który wykazuje stabilność chemiczną i fizyczną minimum 3 dni po pierwszym otwarciu opakowania.

Tender item

ID: ocds-pyfy63:2022-123986:obj:160
Classification: CPV / 33000000
Description: kaps. twarde, 150 mg28/ 150

Award

ID: ocds-pyfy63:2022-123986:award:0
Title: ABEMACICLIBUM
Date: 2022-06-10
Status: active
Suppliers: URTICA SP. Z. O.O.

Award

ID: ocds-pyfy63:2022-123986:award:1
Title: ABIRATERONUM
Date: 2022-06-10
Status: active
Suppliers: JANSSEN-CILAG POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:2
Title: AFATINIBUM
Date: 2022-06-10
Status: active
Suppliers: URTICA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:3
Title: AFLIBERCEPTUM
Date: 2022-06-10
Status: active
Suppliers: SANOFI-AVENTIS SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:4
Title: ALECTINIBUM
Date: 2022-06-10
Status: active
Suppliers: ROCHE POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:5
Title: ANAGRELIDUM
Date: 2022-06-10
Status: active
Suppliers: URTICA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:6
Title: ARSENII TRIOXIDUM
Date: 2022-06-10
Status: active
Suppliers: ASCLEPIOS S.A.

Award

ID: ocds-pyfy63:2022-123986:award:7
Title: ATEZOLIZUMABUM
Date: 2022-06-10
Status: active
Suppliers: ROCHE POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:8
Title: AZACITIDINE
Date: 2022-06-10
Status: active
Suppliers: Lek S.A.

Award

ID: ocds-pyfy63:2022-123986:award:9
Title: BCG AD IMMUNOCURATIONEM
Date: 2022-06-10
Status: active
Suppliers: SALUS INTERNATIONAL SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:10
Title: BCG AD IMMUNOCURATIONEM
Date: 2022-06-10
Status: active
Suppliers: CENTRALA FARMACEUTYCZNA CEFARM SA

Award

ID: ocds-pyfy63:2022-123986:award:11
Title: BENDAMUSTINUM HYDROCHLORIDUM
Date: 2022-06-10
Status: active
Suppliers: ASCLEPIOS S.A.

Award

ID: ocds-pyfy63:2022-123986:award:12
Title: BINIMETINIB
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:13
Title: BLEOMYCINI HYDROCHLORIDUM LUB SULFAS
Date: 2022-06-10
Status: active
Suppliers: SALUS INTERNATIONAL SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:14
Title: BLINATUMOMABUM
Date: 2022-06-10
Status: active
Suppliers: Amgen SP. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:15
Title: BOSUTYNIBUM
Date: 2022-06-10
Status: active
Suppliers: PFIZER TRADING POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:16
Title: BRENTUXIMABUM VEDOTINUM
Date: 2022-06-10
Status: active
Suppliers: Takeda Pharma sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:17
Title: BUSULFANUM
Date: 2022-06-10
Status: active
Suppliers: SALUS INTERNATIONAL SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:18
Title: CABOZANTINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:19
Title: CAPECITABINUM
Date: 2022-06-10
Status: active
Suppliers: SALUS INTERNATIONAL SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:20
Title: CARBOPLATINUM
Date: 2022-06-10
Status: active
Suppliers: SALUS INTERNATIONAL SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:21
Title: CARFILZOMIBUM
Date: 2022-06-10
Status: active
Suppliers: Amgen SP. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:22
Title: CARMUSTINUM
Date: 2022-06-10
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:23
Title: CEMIPLIMABUM
Date: 2022-06-10
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:24
Title: CERITINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:25
Title: CETUXIMAB
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:26
Title: CICLOSPORINUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:27
Title: CICLOSPORIUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:28
Title: CICLOSPORIUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:29
Title: CICLOSPORIUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:30
Title: CISPLATINUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:31
Title: CLADRIBINUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:32
Title: COBIMETINIBUM
Date: 2022-06-10
Status: active
Suppliers: ROCHE POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:33
Title: CRIZOTINIBUM
Date: 2022-06-10
Status: active
Suppliers: PFIZER TRADING POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:34
Title: CYCLOPHOSPHAMIDUM
Date: 2022-06-10
Status: active
Suppliers: BAXTER POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:35
Title: CYCLOPHOSPHAMIDUM
Date: 2022-06-10
Status: active
Suppliers: BAXTER POLSKA SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:36
Title: CYTARABINUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:37
Title: DABRAFENIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:38
Title: DACARBAZINUM
Date: 2022-06-10
Status: active
Suppliers: SALUS INTERNATIONAL SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:39
Title: DACTINOMYCIN
Date: 2022-06-10
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:40
Title: DARATUMUMABUM
Date: 2022-06-10
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:41
Title: DASATYNIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:42
Title: DAUNORUBICINUM
Date: 2022-06-10
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:43
Title: DOCETAXELUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:44
Title: DOXORUBICIN W PEGYLOWANYCH LIPOSOMACH
Date: 2022-06-10
Status: active
Suppliers: Baxter Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:45
Title: "DOXORUBICINA LIPOSOMALNA NIEPEGYLOWANA"
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:46
Title: "DOXORUBICINI HYDROCHLORIDUM LUB DOXORUBICINUM"
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:47
Title: DURVALUMAB
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:48
Title: ENCORAFENIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:49
Title: ENZALUTAMIDUM
Date: 2022-06-10
Status: active
Suppliers: Astellas Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:50
Title: EPIRUBICINI HYDROCHLORIDUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:51
Title: ERLOTINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:52
Title: ETOPOSIDUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:53
Title: EVEROLIMUSUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:54
Title: FEDRATINIBUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:55
Title: FILGRASTIMUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:56
Title: FILGRASTIMUM
Date: 2022-06-10
Status: active
Suppliers: Lek S.A.

Award

ID: ocds-pyfy63:2022-123986:award:57
Title: FLUDARABINI PHOSPHAS
Date: 2022-06-10
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:58
Title: FLUDARABINUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:59
Title: FLUOROURACILUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:60
Title: FULVESTRANTUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:61
Title: GEFITINIBUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:62
Title: GEMCITABINUM
Date: 2022-06-10
Status: active
Suppliers: Lek S.A.

Award

ID: ocds-pyfy63:2022-123986:award:63
Title: GEMTUZUMABUM OZOGAMICINUM
Date: 2022-06-10
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:64
Title: HYDROXYCARBAMIDUM *
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:65
Title: IBRUTYNIBUM
Date: 2022-06-10
Status: active
Suppliers: Janssen-Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:66
Title: IDARUBICINUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:67
Title: IFOSFAMIDUM
Date: 2022-06-10
Status: active
Suppliers: Baxter Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:68
Title: IMATINIBUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:69
Title: IMATINIBUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:70
Title: IMMUMOGLOBULINA KRÓLICZA PRZECIWKO LUDZKIM LIMFOCYTOM T
Date: 2022-06-10
Status: active
Suppliers: Fresenius Nephrocare Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:71
Title: IMMUNOGLOBULINA LUDZKA 10% DO PODAWANIA PODSKÓRNEGO W ZESTAWIE Z REKOMBINOWANĄ HIALURONIDAZĄ LUDZKĄ
Date: 2022-06-10
Status: active
Suppliers: Takeda Pharma sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:72
Title: IMMUNOGLOBULINA LUDZKA DO PODANIA DOŻYLNEGO - 1ML ROZTWORU ZAWIERA 50MG BIAŁKA OSOCZA LUDZKIEGO, W TYM CO NAJMNIEJ 95% IMMUNOGLOBULINY: IMMUNOGLOBULINAM (IGM) 6MG, IMMUNOGLOBULINAA (IGA) 6MG, IMMUNOGL
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:73
Title: IMMUNOGLOBULINA LUDZKA DO PODANIA DOŻYLNEGO - 1ML ROZTWORU ZAWIERA 50MG BIAŁKA OSOCZA LUDZKIEGO, W TYM CO NAJMNIEJ 95% IMMUNOGLOBULINY: IMMUNOGLOBULINAM (IGM) 6MG, IMMUNOGLOBULINAA (IGA) 6MG, IMMUNOGL
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:74
Title: IMMUNOGLOBULINS INTRAVENOUS, ROZTWÓR 10%, ZAWARTOŚĆ IGG ≥ 98%, ZAWARTOŚĆ IGA ≤ 0,025 MG/ML
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:75
Title: IMMUNOGLOBULINS INTRAVENOUS, ROZTWÓR 10%, ZAWARTOŚĆ IGG ≥ 98%, ZAWARTOŚĆ IGA ≤ 0,14 MG/ML
Date: 2022-06-10
Status: active
Suppliers: Takeda Pharma sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:76
Title: IMMUNOGLOBULINUM HUMANUM - PREPARAT O ZAWARTOŚCI: IGG CO NAJMNIEJ 98%; IGA MAX 280µG/ML*
Date: 2022-06-10
Status: active
Suppliers: Takeda Pharma sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:77
Title: IMMUNOGLOBULINUM HUMANUM DO PODANIA PODSKÓRNEGO PREPARAT O ZAWARTOŚCI 1,IGG CO NAJMNIEJ 95% 2.IGA MAX 50UG/ML, FIOL.≤0,2 G/ML
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:78
Title: INFLIXIMABUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:79
Title: IPILIMUMAB
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:80
Title: IRINOTECANUM LUB POCHODNE
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:81
Title: IXAZOMIBUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:82
Title: LANREOTIDUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:83
Title: LAPATINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:84
Title: LENALIDOMIDUM
Date: 2022-06-10
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:85
Title: LENALIDOMIDUM
Date: 2022-06-10
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:86
Title: LENALIDOMIDUM
Date: 2022-06-10
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:87
Title: LENALIDOMIDUM
Date: 2022-06-10
Status: active
Suppliers: TRAMCO SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:88
Title: LOMUSTINUM
Date: 2022-06-10
Status: active
Suppliers: Storkpharm Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:89
Title: LORLATINIBUM
Date: 2022-06-10
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:90
Title: MEGESTROLI ACETAS
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:91
Title: MELPHALANUM
Date: 2022-06-10
Status: active
Suppliers: TRAMCO SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:92
Title: MELPHANALUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:93
Title: METHOTREXATUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:94
Title: METHOXALEN
Date: 2022-06-10
Status: active
Suppliers: TRAMCO SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:95
Title: MIDOSTAURINUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:96
Title: MITOMYCINUM
Date: 2022-06-10
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:97
Title: MITOXANTRONUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:98
Title: MYCOPHENOLATE MOFETIL
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:99
Title: NELARABINUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:100
Title: NILOTYNIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:101
Title: NINTEDANIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:102
Title: NINTEDANIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:103
Title: NINTEDANIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:104
Title: NIRAPARIBUM
Date: 2022-06-10
Status: active
Suppliers: GSK Services Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:105
Title: NIVOLUMABUM + FILTR DO PODANIA LEKU
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:106
Title: OBINUTUZUMABUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:107
Title: OLAPARIBUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:108
Title: OSIMERTTINIBUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:109
Title: OXALIPLATINUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:110
Title: PACLITAXELUM
Date: 2022-06-10
Status: active
Suppliers: Asclepios S.A.

Award

ID: ocds-pyfy63:2022-123986:award:111
Title: "PACLITAXELUM ALBUMINATUM"
Date: 2022-06-10
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:112
Title: PALBOCICLIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:113
Title: PANITUMUMABUM
Date: 2022-06-10
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:114
Title: PAZOPANIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:115
Title: PEGASPARAGASUM
Date: 2022-06-10
Status: active
Suppliers: SERVIER POLSKA SERVICES SP.

Award

ID: ocds-pyfy63:2022-123986:award:116
Title: PEGFILGRASTIMUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:117
Title: PEGINTERFERONUM ALFA-2A
Date: 2022-06-10
Status: active
Suppliers: NEUCA S.A.

Award

ID: ocds-pyfy63:2022-123986:award:118
Title: PEGINTERFERONUM ALFA-2A
Date: 2022-06-10
Status: active
Suppliers: NEUCA S.A.

Award

ID: ocds-pyfy63:2022-123986:award:119
Title: PEMBROLIZUMABUM +ZESTAW DO INFUZJI
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:120
Title: PEMETREXEDUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:121
Title: PERTUZUMABUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:122
Title: PIRFENIDONUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:123
Title: PLERIXAFOR
Date: 2022-06-10
Status: active
Suppliers: Sanofi-Aventis Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:124
Title: POLATUZUMABUM VEDOTINUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:125
Title: POMALIDOMIDUM
Date: 2022-06-10
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:126
Title: PONATINIBUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:127
Title: PROCARBAZINUM
Date: 2022-06-10
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:128
Title: RIBOCICLIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:129
Title: RUXOLITINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:130
Title: RUXOLITINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:131
Title: SIROLIMUSUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:132
Title: SORAFENIBUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:133
Title: SUNITINIBUM
Date: 2022-06-10
Status: active
Suppliers: Egis Polska Dystrybucja Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:134
Title: SUNITINIBUM
Date: 2022-06-10
Status: active
Suppliers: Egis Polska Dystrybucja Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:135
Title: TACROLIMUSUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:136
Title: TACROLIMUSUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:137
Title: TEMOZOLOMIDUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:138
Title: TEMSIROLIMUSUM
Date: 2022-06-10
Status: active
Suppliers: Pfizer Trading Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:139
Title: THALIDOMIDUM
Date: 2022-06-10
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:140
Title: THIOTEPUM
Date: 2022-06-10
Status: active
Suppliers: Imed Poland Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:141
Title: TOPOTECANUM
Date: 2022-06-10
Status: active
Suppliers: NEUCA S.A.

Award

ID: ocds-pyfy63:2022-123986:award:142
Title: TOPOTECANUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:143
Title: TOPOTECANUM
Date: 2022-06-10
Status: active
Suppliers: Salus International Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:144
Title: TRABECTEDINUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:145
Title: TRAMETINIBUM
Date: 2022-06-10
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:146
Title: TRASTUZUMAB EMTANZYNY
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:147
Title: TRASTUZUMABUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:148
Title: TRASTUZUMABUM
Date: 2022-06-10
Status: active
Suppliers: ASCLEPIOS S.A.

Award

ID: ocds-pyfy63:2022-123986:award:149
Title: TRETINOINUM
Date: 2022-06-10
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:150
Title: TRIFLURIDINUM + TIPIRACILUM
Date: 2022-06-10
Status: active
Suppliers: SERVIER POLSKA SERVICES SP. Z O.O.

Award

ID: ocds-pyfy63:2022-123986:award:151
Title: VEDOLIZUMABUM
Date: 2022-06-10
Status: active
Suppliers: Takeda Pharma sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:152
Title: VEMURAFENIBUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Award

ID: ocds-pyfy63:2022-123986:award:153
Title: VENETOCLAXUM
Date: 2022-06-10
Status: active
Suppliers: ABBVIE sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:154
Title: VINBLASTINI SULFAS
Date: 2022-06-10
Status: active
Suppliers: Storkpharm Sp. z o.o.

Award

ID: ocds-pyfy63:2022-123986:award:155
Title: VINCRISTINI SULFAS
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:156
Title: VINORELBINUM
Date: 2022-06-10
Status: active
Suppliers: ASCLEPIOS S.A.

Award

ID: ocds-pyfy63:2022-123986:award:157
Title: VINORELBINUM
Status: unsuccessful

Award

ID: ocds-pyfy63:2022-123986:award:158
Title: VINORELBINUM
Date: 2022-06-10
Status: active
Suppliers: ASCLEPIOS S.A.

Award

ID: ocds-pyfy63:2022-123986:award:159
Title: VISMODEGIBUM
Date: 2022-06-10
Status: active
Suppliers: Roche Polska Sp. z o.o

Parties

Roles: buyer
Organization name: Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii
Street address: pl. Hirszfelda 12
Locality: Wrocław
Postal code: 53-413
Country: PL
Contact name: Jolanta Harłacz-Przestalska
E-mail: dzp@dco.com.pl
Phone: +48 713689585
Fax: +48 713689583
Website: Link